Copyright
©The Author(s) 2021.
World J Gastroenterol. May 28, 2021; 27(20): 2576-2585
Published online May 28, 2021. doi: 10.3748/wjg.v27.i20.2576
Published online May 28, 2021. doi: 10.3748/wjg.v27.i20.2576
Figure 1 Organs of human body (different from lung and liver) in which angiotensin-converting enzyme 2 was detected, the main site of expression and the possible coronavirus disease 2019 related symptoms/complications are reported in the corresponding columns.
COVID-19: Coronavirus disease 2019; ACE2: Angiotensin-converting enzyme 2.
Figure 2 The putative mechanisms inducing liver injury in the course of coronavirus disease 2019 are reported in the left side of the figure (? = controversial data on the specific mechanism).
The right part describes the possible outcome according to patient baseline liver condition. NAFLD: Non-alcoholic fatty-liver-disease; COVID-19: Coronavirus disease 2019.
- Citation: Signorello A, Lenci I, Milana M, Grassi G, Baiocchi L. COVID-19 in normal, diseased and transplanted liver. World J Gastroenterol 2021; 27(20): 2576-2585
- URL: https://www.wjgnet.com/1007-9327/full/v27/i20/2576.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i20.2576